Literature DB >> 20371956

Treatment of pretibial myxedema (PTM) with topical steroid ointment application with sealing cover (steroid occlusive dressing technique: steroid ODT) in Graves' patients.

Nobuyuki Takasu1, Haruyo Higa, Yoshino Kinjou.   

Abstract

Localized pretibial myxedema (PTM) is a sign of Graves' disease. A 53-year-old man with Graves' disease was admitted with the development of PTM following radioisotope (131)I treatment for Graves' hyperthyroidism. TSH receptor antibody (TRAb) titer was also increased after (131)I treatment. TRAb was measured as thyroid stimulating antibody (TSAb) or TSH-binding inhibitory immunoglobulin (TBII). PTM was noted several months after (131)I treatment. The PTM-development seems to be associated with the increased TRAb-activities. The localized pretibial myxedema was effectively treated with topical steroid (triamcinolone acetonide) ointment application with sealing cover (steroid occlusive dressing technique: steroid ODT). We also report our experience of PTM-treatment with steroid ODT in 5 other PTM patients with positive TRAb. PTM was successfully treated with steroid ODT in two patients. In these two patients, the treatment was started within several months of the appearance of PTM. In the other 4 patients, the treatment was started 5-10 years after the appearance of PTM without any beneficial effects. Early detection and early treatment are necessary for the remission of PTM.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20371956     DOI: 10.2169/internalmedicine.49.2617

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  6 in total

Review 1.  Extrathyroidal manifestations of Graves' disease: a 2014 update.

Authors:  Luigi Bartalena; Vahab Fatourechi
Journal:  J Endocrinol Invest       Date:  2014-06-10       Impact factor: 4.256

2.  Morphological Diversity of Pretibial Myxedema and Its Mechanism of Evolving Process and Outcome: A Retrospective Study of 216 Cases.

Authors:  Changgui Lan; Yi Wang; Xia Zeng; Jing Zhao; Xiaoxi Zou
Journal:  J Thyroid Res       Date:  2016-08-25

3.  Treatment of pretibial myxedema with intralesional immunomodulating therapy.

Authors:  Ziwei Ren; Min He; Fang Deng; Yan Chen; Liyin Chai; Bing Chen; Wuquan Deng
Journal:  Ther Clin Risk Manag       Date:  2017-09-08       Impact factor: 2.423

4.  Intralesional and topical glucocorticoids for pretibial myxedema: A case report and review of literature.

Authors:  Fan Zhang; Xin-Yue Lin; Jian Chen; Shi-Qiao Peng; Zhong-Yan Shan; Wei-Ping Teng; Xiao-Hui Yu
Journal:  World J Clin Cases       Date:  2018-11-26       Impact factor: 1.337

5.  [Pretibial myxoedema in Graves' disease].

Authors:  Alejandra Tomás-Velázquez; Pablo Panadero Meseguer; Leyre Aguado
Journal:  Aten Primaria       Date:  2019-03-04       Impact factor: 1.137

6.  A Randomized Controlled Trial of Intralesional Glucocorticoid for Treating Pretibial Myxedema.

Authors:  Changgui Lan; Can Li; Wei Chen; Xiaofeng Mei; Jing Zhao; Jie Hu
Journal:  J Clin Med Res       Date:  2015-09-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.